Mike Kelly
Tell me more about Mike Kelly?
Mike Kelly is an experienced professional with 18.9 years of work experience in the biotechnology industry. He has a strong background in operational excellence, gene therapy, technical due diligence, and process development. Mike has held various leadership positions in reputable companies such as AVROBIO, Biogen, and Atsena Therapeutics. He has a proven track record in the field and has contributed to the success of these organizations. Mike is currently based in the United States.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
Work Experience
senior vice president cmc at atsena therapeutics
Biotechnology Research
Mike Kelly's Professional Milestones
- Director, Adpm Gene Therapy (2015-01-01~2019-01-01): Optimized adPM gene therapy through strategic initiatives, increasing patient outcomes and enhancing regulatory compliance.
- senior vice president cmc at atsena therapeutics: Driving company success through effective marketing strategies and successful market share management.
Skill
Biotechnology
Operational Excellence
Gene Therapy
Technical Due Diligence
Process Development
Certification
Colleagues
Mallory Bissett, MBA
vice president clinical operations at atsena therapeutics
Elisabeth Leiderman, MD, MBA
Chief Financial Officer | Chief Business Officer
Kenji Fujita
chief medical officer at atsena therapeutics
Rachel Smith
Vice President Of Regulatory Affairs
Eva Andres-Mateos
Vice President Of Translational Research
Other Named Mike Kelly
Frequently asked questions
We found 1 Mike Kelly's email addresses
Mike Kelly's social media include: Linkedin,
Mike Kelly works for Atsena Therapeutics
Mike Kelly's role in Atsena Therapeutics is senior vice president cmc at atsena therapeutics
Mike Kelly works in the industry of Biotechnology Research
Mike Kelly's colleagues are Mallory Bissett, MBA,Elisabeth Leiderman, MD, MBA,Kenji Fujita
Mike Kelly's latest job experience is senior vice president cmc at atsena therapeutics at Atsena Therapeutics